-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Ecopipam Hydrochloride in Restless Legs Syndrome
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ecopipam Hydrochloride in Restless Legs Syndrome report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ecopipam Hydrochloride in Restless Legs Syndrome Drug Details: Ecopipam hydrochloride...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Botensilimab in Colorectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Botensilimab in Colorectal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Botensilimab in Colorectal Cancer Drug Details: AGEN-1181 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AGI-134 in Endometrial Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. AGI-134 in Endometrial Cancer Drug Details: AGI-134 is under development for the treatment of solid...
-
Product Insights
Tourette Syndrome – Drugs In Development, 2023
Global Markets Direct’s, ‘Tourette Syndrome - Drugs In Development, 2023’, provides an overview of the Tourette Syndrome pipeline landscape. The report provides comprehensive information on the therapeutics under development for Tourette Syndrome, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Restless Legs Syndrome – Drugs In Development, 2023
Global Markets Direct’s, ‘Restless Legs Syndrome - Drugs In Development, 2023’, provides an overview of the Restless Legs Syndrome pipeline landscape. The report provides comprehensive information on the therapeutics under development for Restless Legs Syndrome, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ecopipam Hydrochloride in Tourette Syndrome
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Ecopipam Hydrochloride in Tourette Syndrome Drug Details:Ecopipam hydrochloride (PSYRX-101) is under development for the treatment of...
-
Product Insights
Tourette Syndrome Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Tourette Syndrome Clinical Trials Market Report Overview The Tourette Syndrome clinical trial market research report provides an overview of the Tourette Syndrome Clinical trials scenario. This report provides top-line data relating to the clinical trials on Tourette Syndrome and includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report also offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type....
-
Product Insights
Tourette Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Tourette syndrome (TS) is a neurological disorder characterized by repetitive, stereotyped, involuntary movements and vocalizations called tics. Symptoms include eye blinking and other eye movements, facial grimacing, shoulder shrugging, and head or shoulder jerking. Other symptoms include touching the nose, smelling objects, flapping the arms, and hopping. The predisposing factors include age. Males are about three to four times more likely than females to develop Tourette syndrome. Treatment includes antidepressants, stimulant medications and behavior therapy. The Tourette syndrome drugs in...
-
Product Insights
Tourette Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2021 Update
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Tourette Syndrome - Drugs in Development, 2021, provides an overview of the Tourette Syndrome (Central Nervous System) pipeline landscape. Tourette syndrome (TS) is a neurological disorder characterized by repetitive, stereotyped, involuntary movements and vocalizations called tics. Symptoms include eye blinking and other eye movements, facial grimacing, shoulder shrugging, and head or shoulder jerking. Other symptoms include touching the nose, smelling objects, flapping the arms and hopping. The predisposing factors include...
-
Product Insights
Brucellosis Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Brucellosis Global Clinical Trials Review, H2, 2018" provides an overview of Brucellosis clinical trials scenario. This report provides top line data relating to the clinical trials on Brucellosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...